Quan Capital is a life sciences venture firm with a global vision and capabilities combined with unique China strengths. It invests in innovative early and growth stage life sciences companies, with primary focus on therapeutics and related areas, including enabling technologies and high-end services, etc.
The Quan team is led by seasoned investment professionals with a strong track record of consistently high returns. They are highly successful company builders with deep industry knowledge across the biopharma value chain.
With presence in both China and the US, Quan leverages its expertise in cross-border value creation with strong local execution capabilities.
We identify, incubate, and invest in innovative early and growth stage companies globally, with a focus on:
▪ Therapeutic biotech/pharma
▪ Enabling technologies/High-end specialty services
▪ Companion diagnostic & Precision medicine
People
- Samantha Du, Founding Managing Director
You last contacted this investor on .